机构：[1]Department of Respiratory and Critical Care Medicine Institute of Respiratory Health Center of Precision Medicine West China Hospital Sichuan University Chengdu Sichuan Province China.四川大学华西医院
This work was supported by the Clinical Research
Incubation Project of West China Hospital of Sichuan
University (2018HXFH012), Science and Technology
Foundation of Sichuan Province, China (2020YFS0572)
and the National Natural Science Foundation of China
(82200078).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2025]版：
大类|1 区医学
小类|1 区医学：研究与实验
最新[2025]版：
大类|1 区医学
小类|1 区医学：研究与实验
第一作者：
第一作者机构：[1]Department of Respiratory and Critical Care Medicine Institute of Respiratory Health Center of Precision Medicine West China Hospital Sichuan University Chengdu Sichuan Province China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Gan Jiadi,Wu Jiaxuan,Zhang Huohuo,et al.Immunotherapy against lung cancer does not need to compromise the outcomes of COVID-19[J].Medcomm.2024,5(1):e451.doi:10.1002/mco2.451.
APA：
Gan Jiadi,Wu Jiaxuan,Zhang Huohuo,Liu Dan&Li Weimin.(2024).Immunotherapy against lung cancer does not need to compromise the outcomes of COVID-19.Medcomm,5,(1)
MLA：
Gan Jiadi,et al."Immunotherapy against lung cancer does not need to compromise the outcomes of COVID-19".Medcomm 5..1(2024):e451
医学